Results -Neutrophils predominated in the sputum of subjects with COPD while eosinophils predominated in the sputum of those with chronic asthma. However, in 28% of asthmatic subjects an increased percentage of neutrophils was found. In asthmatic patients the differential count of eosinophils was inversely related to the FEV1, FEV1NVC, and bronchial hyperresponsiveness, and directly related to clinical scores.
M C Ronchi, C Piragino, E Rosi, M Amendola, R Duranti, G Scano Abstract Background -Sputum may provide an alternative source of bronchial cells to investigate characteristics of airway inflammation and its functional correlates in patients with asthma or chronic obstructive pulmonary disease (COPD). Methods -Two groups of clinically stable patients were studied: a group of 43 patients with mild or moderate asthma and a group of 18 patients with COPD. Twenty normal subjects formed a control group. Sputum production was either spontaneous or induced with inhaled hypertonic saline for five minute periods for up to 20 minutes. The concentration of saline was increased at intervals of 10 minutes from 3% to 4%. Plugs from the lower respiratory tract were selected for differential counting in cytocentrifugation preparations. Bronchial provocation tests were performed by inhaling progressive concentrations ofhistamine from a DeVilbiss 646 nebuliser and the concentration of histamine which caused a 20% fall in the forced expiratory volume in one second (FEV1 ) was calculated (PC20FEV1).
Results -Neutrophils predominated in the sputum of subjects with COPD while eosinophils predominated in the sputum of those with chronic asthma. However, in 28% of asthmatic subjects an increased percentage of neutrophils was found. In asthmatic patients the differential count of eosinophils was inversely related to the FEV1, FEV1NVC, and bronchial hyperresponsiveness, and directly related to clinical scores.
Conclusions -The cellular profile of sputum in normal subjects and in patients with asthma and COPD is different. The concentration of eosinophils in the sputum correlates with the severity of asthma. (Thorax 1996 ;51:1000-1004) Keywords: sputum, asthma, COPD.
Airway inflammation plays an important part in the pathogenesis of asthma`and chronic obstructive pulmonary disease (COPD).5 [7] [8] [9] [10] [11] The cellular inflammatory response of the bronchial mucosa is characterised by infiltration of eosinophils and mast cells in asthma,3 6 8 while infiltration of macrophages, neutrophils, T lymphocytes but not eosinophils is thought to be the predominant pattern in COPD.5-' 1012 Recent studies'3 14 have also shown neutrophil inflammation in sputum from asthmatic subjects during exacerbations.
Use of induced sputum cell counts"15-" has recently been proposed as a non-invasive alternative to bronchoalveolar lavage (BAL) to investigate airway inflammation in asthma and COPD. Sputum examination may also be used to differentiate the inflammatory characteristics of asthma from those of other airway diseases. Inflammatory changes in sputum have been reported to correlate with disease severity15 16 in asthma. The present study was carried out in an attempt to investigate the cell profile in the sputum of patients with asthma and COPD and to investigate its relation to airflow obstruction.
Methods

SUBJECTS
Forty three patients with chronic bronchial asthma, 18 with chronic obstructive pulmonary disease (COPD), and 20 normal subjects participated in the study. Informed consent was given by each patient and the study was approved by the local ethics committee.
The normal subjects were an age matched group of 20 healthy, lifelong non-smoking, non-allergic subjects aged 12 patients had been given inhaled bronchodilators on demand, 16 required regular inhaled bronchodilator therapy, 15 received daily inhaled corticosteroids, and 11 received daily oral corticosteroids. Six patients were on no drugs. All bronchodilators were withheld for at least 12 hours before each study. All subjects had been free from acute respiratory infections during the preceding six weeks and were stable at the time of study.
Patients with COPD complained of cough and sputum on most days in the month for years and exhibited moderate to severe (FEV1NC 20-60%) and irreversible airway obstruction (increase in FEV, < 10% after inhalation of 200 ,ug fenoterol) according to ATS criteria.20 Before entering the study nine patients received daily inhaled corticosteroids and regular inhaled bronchodilator therapy. All bronchodilators were withheld for at least 12 hours before each study. No patients had had recent exacerbations defined as a change in quality and quantity of sputum with increased dyspnoea.
STUDY DESIGN
On day 1 a questionnaire on the characteristics and clinical scores of the patients was completed and baseline spirometric tests, skin prick tests to a battery of common aeroallergen extracts, and total serum IgE (RIST) were also performed. On day 2 the histamine inhalation test was performed. On day 3 sputum was induced in normal and asthmatic subjects and spontaneous sputum was collected from patients with COPD. Eighteen patients (10 asthmatics and eight with COPD) were asked to produce sputum on a second occasion within one week. All of the sputum from normal subjects and patients with asthma was collected as induced sputum, and all of the sputum from patients with COPD was spontaneously expectorated. LUNG Table 1 shows the anthropometric and clinical characteristics of the three groups. The groups significantly differed in age, patients with COPD being the oldest. As might be expected, patients with COPD smoked much more than asthmatics. PC20FEV1 was similar in asthmatic patients and those with COPD. The level of serum IgE (range 12-5069 U/ml in asthmatic subjects and 2-1939 U/ml in those with COPD) did not differ significantly among the patients. Skin prick tests were positive, with a wheal diameter of 3 mm or more, in 27 asthmatic subjects and in one with COPD.
FEV1 (% predicted) was lower in patients with
COPD and asthmatic patients than in normal subjects, being lower in patients with COPD than in asthmatics.
The total number of cells in the sputum was similar in the three groups (table 2, fig 1) . The differential count showed more eosinophils in asthmatic patients than in normal subjects and patients with COPD, and significantly more neutrophils in patients with COPD than in asthmatic patients and normal subjects. Nonetheless, in 12 asthmatic patients the differential count of neutrophils was higher than in normal subjects. The number of macrophages was lower in patients with COPD than in asthmatics, and no difference was seen in the repeatability coefficients"4 of the differential cell counts were 9.2 for eosinophils and 11.6 for neutrophils. Table 3 shows the relationships between cellular profile, clinical, and functional data. In asthmatic patients the eosinophil count (%) was directly related to clinical scores and inversely related to the percentage predicted (table 4) . Thus, the present data do not help in defining the contribution of neutrophils to asthma.
In conclusion, examination of sputum is a potential tool for clinical studies aimed at defining the cytological profile and evaluating interrelations between cellular and clinical patterns of airway inflammation in patients with asthma and COPD.
